Phase 2 Study of Azacitidine (Vidaza) vs MGCD0103 vs Combination in Elderly Subjects With Newly Diagnosed Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
Clinical trial NCT00666497 · TERMINATED
Trial details
- NCT number
- NCT00666497
- Sponsor
- Mirati Therapeutics Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-06-01
- Primary completion
- 2009-04-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.